• About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
  • About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure

New Collection of Canine Cancer Cell Lines

Canine cancer cell lines for identification of new targetable drug and immunotherapy pathways

At a Glance

This offering consists of 18 canine cancer cell lines generated from tumor biopsies of patients treated at the CSU Flint Animal Cancer Center. Several rare cancer types are represented in the collection.

Background

18 canine cancer cell lines were generated from tumor biopsies of dogs. The types of cancers represented include melanoma, osteosarcoma, mammary carcinoma, lung adenocarcinoma, bronchoalveolar carcinoma, thyroid follicular cell adenocarcinoma, soft tissue sarcoma, squamous cell carcinoma, histiocyticsarcoma, gastric adenocarcinoma, and colonic adenocarcinoma.

Overview

Cell lines are a crucial tool in oncology research and drug screening. Investigators at the Colorado State University Veterinary Teaching Hospital and Flint Animal Cancer Center have developed a series of canine cancer cell lines from tumor biopsies, including rare tumors of the GI tract and lungs.  These cells lines are valuable for identifying drug and immunotherapy targets for new canine therapeutics, as well as for comparison with analogous human cancer cell lines.

Benefits

  • Established cell lines to screen drug candidates and immunotherapies for canine cancer.

Applications

  • Drug screening
Last Updated: August 2024
A beagle resting its head on a couch, looking off into the distance with a thoughtful expression.
Opportunity

Available for Non-Exclusive Licensing

Inventors

Steven Dow
Lyndah Chow
Alison Manchester

Reference Number
2024-072
Licensing Manager

Steve Foster
Steve.Foster@colostate.edu
970-491-7100

Contact Us About this Technology
Download PDF
Download
Strata logo white
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
Serving the Colorado State University System with strategic real estate services, intellectual property protection and licensing, and financing activities.
Integrity
Reliability
Respect
Innovation
Excellence
Submit Disclosure

Newsletter Sign Up

Connect